Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. We enable global health equality by bringing affordable drugs to treat underserved people suffering from critical diseases. Xbrane posses world leading expertise in developing true generics for injectable controlled release drugs and proprietary high-yield protein expression technology.
View Top Employees from Xbrane Biopharma ABWebsite | http://www.xbrane.com |
Revenue | $12.2 million |
Employees | 89 (81 on RocketReach) |
Founded | 2008 |
Address | 22 Banvaktsvägen, Solna 17148, SE |
Phone | +46 76 309 37 77 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology, Business Services General, Complex generics, Business Services, Science and Engineering, Drug Discovery, Protein expression, Biosimilars, Controlled release, Strain development, Formulation |
Web Rank | 6 Million |
Keywords | Biosimilars, Affordable, Drug Development And Manufacturing, Generic Drugs, Biopharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Xbrane Biopharma AB employee's phone or email?
The Xbrane Biopharma AB annual revenue was $12.2 million in 2024.
Anette Lindqvist is the Chief Financial Officer and Head of Investor Relations of Xbrane Biopharma AB.
81 people are employed at Xbrane Biopharma AB.
The NAICS codes for Xbrane Biopharma AB are [325, 3254, 32, 32541].
The SIC codes for Xbrane Biopharma AB are [283, 28].